Health and Human Services Committee
February 13, 2025
Committee Chair: Sen. Brian Hardin | Bills Heard: 1 | Full Transcript (PDF)
LB512: Chemical Abortion Safety Protocol Act
Introduced by: Sen. Rick Holdcroft | Testimony: 278 proponents, 406 opponents, 20 neutral | Read bill text (PDF)
Nebraska committee hears sharply divided testimony on medication abortion safety bill. LB512 would require providers to screen for ectopic pregnancy, schedule follow-up visits within 3-14 days, and report complications for medication abortions—but the Health and Human Services Committee heard starkly different assessments of whether the bill protects women or restricts access.
Why it matters: Medication abortion accounts for 82% of Nebraska abortions. The bill targets documented violations at the Bellevue facility, where 229 women were dispensed abortion drugs by unlicensed individuals in a three-month period. But medical organizations argue the requirements are medically unnecessary and will burden rural patients and complicate miscarriage care.
What they're saying:
Proponents: "No pregnant woman should ever be neglected or endangered by a careless abortion provider," Sen. Holdcroft said. Supporters cited a 20% complication rate in European studies, ectopic pregnancy risks, and testimony from a woman who experienced severe bleeding with no follow-up care. They argued the bill targets only elective abortions at clinics, not OB-GYN miscarriage management.
Opponents: The Nebraska Medical Association, ACOG, and Planned Parenthood argued medication abortion is safer than many routine procedures (0.3-0.4% complication rate) and that ACOG guidelines don't require in-person follow-up. Dr. Mary Kinyoun warned the bill will confuse pharmacists and delay miscarriage treatment. "Legislating medicine prevents evolution of guidelines as research changes," Dr. Elizabeth Constance testified.
By the numbers: Online testimony: 278 proponents, 406 opponents, 20 neutral. The Bellevue facility violations involved 89% of patients seen during a three-month sampling period.
What's next: No vote was taken. Sen. Riepe suggested targeting bad actors through Joint Commission accreditation requirements rather than broad legislation. Sen. Holdcroft indicated openness to working with committee members on amendments to narrow the bill's scope.
Committee sentiment: Supportive: Sen. Glen Meyer, Sen. Ben Hansen Skeptical: Sen. John Fredrickson, Sen. Merv Riepe Unclear: Sen. Dan Quick, Sen. Carolyn Ballard
Sentiment estimated from questions and comments — not stated positions.
Session Notes
The committee used an annotated process, rotating between proponents, opponents, and neutral testifiers in one-hour blocks to allow witnesses to leave without waiting all day. Chair Hardin noted that online testimony showed 278 proponents, 406 opponents, and 20 neutral positions. The hearing lasted approximately 6 hours. Sen. Holdcroft indicated he would be willing to work with committee members, particularly Sen. Riepe, on amendments to address concerns about the bill's scope and application to non-abortion medical care.
Generated by NE Wire Service | Source: Nebraska Legislature Transcribers Office This is an AI-generated summary. Verify all claims against the official transcript.